Financhill
Sell
36

ASTH Quote, Financials, Valuation and Earnings

Last price:
$30.5100
Seasonality move :
11%
Day range:
$29.7250 - $31.4500
52-week range:
$23.1200 - $63.2000
Dividend yield:
0%
P/E ratio:
34.31x
P/S ratio:
0.72x
P/B ratio:
1.94x
Volume:
272.6K
Avg. volume:
369K
1-year change:
-27.27%
Market cap:
$1.4B
Revenue:
$2B
EPS (TTM):
$0.89

Earnings Data

Next earnings date for ASTH
May 07
2025
Most recent earnings per share
-$0.15
Missed by $0.36
(Feb 27/2025)
Consensus Estimate
$0.21
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ASTH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/07/2025 Q1 $628.1M -- -- $0.38 --
02/27/2025 Q4 $617.2M $665.2M -$0.15 $0.21 -$0.36
11/07/2024 Q3 $462.4M $478.7M $0.33 $0.38 -$0.05
08/07/2024 Q2 $440.8M $486.3M $0.40 $0.56 -$0.16
05/07/2024 Q1 $413.8M $404.4M $0.31 $0.29 $0.02
02/27/2024 Q4 $341.2M $353M $0.26 $0.22 $0.04
09/30/2023 Q3 $350.1M $348.2M $0.47 $0.32 $0.15
06/30/2023 Q2 $342.9M $348.2M $0.28 $0.35 -$0.07
03/31/2023 Q1 $318.1M $337.2M $0.28 $0.46 -$0.18
12/31/2022 Q4 -- $294.2M -$0.06 -- --
09/30/2022 Q3 -- $317M $0.50 -- --
06/30/2022 Q2 -- $269.7M $0.26 -- --
03/31/2022 Q1 -- $263.3M $0.30 -- --
12/31/2021 Q4 -- $195.1M $0.30 -- --
09/30/2021 Q3 -- $227.1M $0.74 -- --
06/30/2021 Q2 -- $175.6M $0.28 -- --
03/31/2021 Q1 -- $176.1M $0.30 -- --
12/31/2020 Q4 -- -$140.1M $0.27 -- --
09/30/2020 Q3 -- $180.1M $0.45 -- --
06/30/2020 Q2 -- $165.2M $0.19 -- --
03/31/2020 Q1 -- $165.1M $0.11 -- --
12/31/2019 Q4 -- $178.8M $0.18 -- --
09/30/2019 Q3 -- $156.1M $0.10 -- --
06/30/2019 Q2 -- $130.1M $0.09 -- --
03/31/2019 Q1 -- $95.8M $0.00 -- --
12/31/2018 Q4 -- $105.5M -$0.10 -- --
09/30/2018 Q3 -- $167.3M $0.24 -- --
06/30/2018 Q2 -- $123M $0.08 -- --
03/31/2018 Q1 -- $124.2M $0.07 -- --
09/30/2017 Q3 -- $40.5M -$0.64 -- --
06/30/2017 Q2 -- $41.6M -$0.60 -- --
03/31/2017 Q1 -- $14.8M -$0.76 -- --
12/31/2016 Q4 -- $15.7M -$0.29 -- --
09/30/2016 Q3 -- $14.6M -$0.23 -- --
06/30/2016 Q2 -- $12.4M -$0.22 -- --
03/31/2016 Q1 -- $11.8M -$0.79 -- --
12/31/2015 Q4 -- $10.7M -$0.31 -- --
09/30/2015 Q3 -- $11.4M -$0.11 -- --
06/30/2015 Q2 -- $10.2M -$0.51 -- --
03/31/2015 Q1 -- $9.6M $0.04 -- --

Astrana Health Earnings Questions

  • How Much did Astrana Health Generate in Revenue Last Quarter?

    Astrana Health reported $665.2M worth of top line sales in its most recent quarter.

  • Did Astrana Health Beat Earnings Last Quarter?

    Astrana Health announced earnings per share of -$0.15 which represents a miss of analyst forecast a $0.21 per share.

  • Is Astrana Health Profitable?

    Astrana Health reported $50.5M that represents $1.05 per share over the last quarter.

  • What is the Analyst Consensus for Astrana Health EPS Next Year?

    Astrana Health's earnings are forecast to grow from $0.90 per share to $1.87 per share next year representing an increase of 107.78%.

  • When is Astrana Health's Earnings Date?

    Astrana Health's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Why Did Buffett Sell the S&P 500?
Why Did Buffett Sell the S&P 500?

Warren Buffett has always been an advocate of investing in…

Will SoundHound AI Stock Recover?
Will SoundHound AI Stock Recover?

SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

Sell
24
AIR alert for Mar 29

AAR [AIR] is down 16.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock